Maintenance is an active phase of treatment
The UK licence names weight maintenance directly. Your dose and the decision to continue should reflect your response, side effects and interactions. Nobody has to stay on the highest dose forever by default. Follow-up still matters once the fastest weight change is over.
If you take Foundayo for diabetes, you also need ongoing glucose care. A stable weight does not mean your diabetes no longer needs treatment. If you stop the medicine, your team should review your glucose plan as well as your weight plan.
Read switching and maintenance headlines with care
A study of people moving from another treatment answers one question about one switch in a chosen group of patients. The study gives no basis for stopping an injection and starting Foundayo yourself at any dose you pick. The form of the medicine, the timing and medical supervision all still matter.
Long-term convenience counts, but no medicine guarantees your weight stays stable for good after you stop. If your appetite returns or your weight goes up, ask for a review. Weight regain is no personal failure. The next step might be support, tests or a treatment decision.
Plan for supply gaps and cost early
Talk through how long treatment is likely to last, the ongoing prescription costs and how reviews will run. Ask what happens if supply is interrupted or your provider withdraws the service. With a clear plan in place, you will not feel pressure to improvise doses when a pack runs out.
If cost is starting to bite, raise the problem before you miss several weeks. A clinician will go through your options and explain the effects of stopping or switching. An unregulated substitute, or tablets spread over a schedule nobody prescribed, makes both safety and effect uncertain.
Support helps whether you continue or stop
Enough good food, regular activity at a level you manage, sleep and psychological support stay useful the whole way through. None of these will fully cancel the biological effects of stopping a medicine. Avoid anyone who promises discipline alone will stop all regain.
Agree a clear point for a follow-up review: a steady weight trend, symptoms coming back, worse glucose or difficulty with appetite. Reaching this point should lead to a supportive review, with no blame and no automatic prescription. If an eating disorder or severe distress is involved, specialist help may matter more than a new weight target.
Some people hear maintenance as the end of decision-making. Your health, other medicines, budget and preferences will change over time. Build in regular reassessment even when treatment seems stable, and keep a clear way to raise new concerns between planned appointments.
Questions to take to your appointment
Ask how your ongoing dose will be chosen and what the plan is after a supply gap or a decision to stop. If you have diabetes, ask for clear arrangements for glucose monitoring and any other treatment you will need.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- Foundayo UK Summary of Product Characteristics medicines.org.uk
- Foundayo UK patient information leaflet medicines.org.uk
- MHRA UK authorisation announcement gov.uk
Spotted something out of date? Report a mistake.